سعر بيوتيكافلوكس 750مجم 7 اقراص 2025

Egyptian Vitabiotics levofloxacin 750 mg film-coated tablets, pack of 7.

• Community-acquired and nosocomial pneumonia, complicated and uncomplicated skin/skin-structure infections, chronic bacterial prostatitis, complicated UTI and acute pyelonephritis, and (reserved) uncomplicated UTI, acute bacterial exacerbation of chronic bronchitis and acute bacterial sinusitis, caused by designated susceptible bacteria in adults.Population: Adults (and pediatric anthrax/plague where indicated)DailyMed / FDA (Major Pharmaceuticals levofloxacin tablets)

• Most common adverse reactions (≥3%): nausea, headache, diarrhea, insomnia, constipation and dizziness.International label, same formulation · DailyMed / FDA (Major Pharmaceuticals levofloxacin tablets)

• Known hypersensitivity to levofloxacin or other quinolone antibacterials.International label, same formulation · DailyMed / FDA (Major Pharmaceuticals levofloxacin tablets)

• BOXED WARNING: Fluoroquinolones, including levofloxacin, associated with disabling and potentially irreversible serious adverse reactions that may occur together (tendinitis/tendon rupture, peripheral neuropathy, CNS effects); discontinue immediately and avoid fluoroquinolones if these occur. May exacerbate myasthenia gravis—avoid in patients with known history. Reserve for uncomplicated UTI, ABECB and ABS when no alternative options exist.International label, same formulation · DailyMed / FDA (Major Pharmaceuticals levofloxacin tablets)
• Risk of tendinitis and tendon rupture (especially Achilles), higher if age >60, corticosteroid use, or transplant; peripheral neuropathy that may be irreversible; CNS effects including seizures and psychiatric reactions; QT prolongation; C. difficile–associated diarrhea; hepatotoxicity; aortic aneurysm/dissection risk; blood glucose disturbances; photosensitivity.International label, same formulation · DailyMed / FDA (Major Pharmaceuticals levofloxacin tablets)

• Published human data have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal/fetal outcomes; animal data showed fetal toxicity at high doses in rats without teratogenicity at exposures up to ~9.4× MRHD.International label, same formulation · DailyMed / FDA (Major Pharmaceuticals levofloxacin tablets)
• Levofloxacin is present in human milk. For most indications, consider pumping and discarding milk during treatment and for 2 additional days after the last dose, or advise that breastfeeding is not recommended during that period.International label, same formulation · DailyMed / FDA (Major Pharmaceuticals levofloxacin tablets)

• Levofloxacin: Inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, blocking DNA replication, transcription, repair and recombination.